Trials / Sponsors / Tvardi Therapeutics, Incorporated
Tvardi Therapeutics, Incorporated
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 2 | 2023-05-15 |
| Recruiting | A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2023-03-23 |
| Terminated | Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Neg Breast Cancer | Phase 1 | 2023-01-09 |
| Completed | Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer | Phase 1 | 2017-11-15 |